Your browser doesn't support javascript.
loading
Impact of SPARC expression on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials.
Ormanns, Steffen; Haas, Michael; Baechmann, Sibylle; Altendorf-Hofmann, Annelore; Remold, Anna; Quietzsch, Detlef; Clemens, Michael R; Bentz, Martin; Geissler, Michael; Lambertz, Helmut; Kruger, Stephan; Kirchner, Thomas; Heinemann, Volker; Boeck, Stefan.
Afiliación
  • Ormanns S; Institute of Pathology, Ludwig-Maximilians Universität München, Thalkirchner Strasse 36, D-80337 Munich, Germany.
  • Haas M; Department of Internal Medicine III and Comprehensive Cancer Center, Klinikum Grosshadern, Ludwig-Maximilians Universität München, Marchioninistrasse 15, D-81377 Munich, Germany.
  • Baechmann S; Institute of Pathology, Ludwig-Maximilians Universität München, Thalkirchner Strasse 36, D-80337 Munich, Germany.
  • Altendorf-Hofmann A; Department of Internal Medicine III and Comprehensive Cancer Center, Klinikum Grosshadern, Ludwig-Maximilians Universität München, Marchioninistrasse 15, D-81377 Munich, Germany.
  • Remold A; Department of Surgery, Jena University Hospital, Jena, Germany.
  • Quietzsch D; Institute of Pathology, Ludwig-Maximilians Universität München, Thalkirchner Strasse 36, D-80337 Munich, Germany.
  • Clemens MR; Department of Internal Medicine III and Comprehensive Cancer Center, Klinikum Grosshadern, Ludwig-Maximilians Universität München, Marchioninistrasse 15, D-81377 Munich, Germany.
  • Bentz M; Department of Internal Medicine II, Klinikum Chemnitz gGmbH, Chemnitz, Germany.
  • Geissler M; Department of Hematology and Oncology, Mutterhaus der Boromaeerinnen, Trier, Germany.
  • Lambertz H; Department of Internal Medicine III, Klinikum Karlsruhe, Karlsruhe, Germany.
  • Kruger S; Department of Gastroenterology and Oncology, Klinikum Esslingen, Esslingen, Germany.
  • Kirchner T; Department of Hematology and Oncology, Klinikum Garmisch-Partenkirchen, Garmisch-Partenkirchen, Germany.
  • Heinemann V; Department of Internal Medicine III and Comprehensive Cancer Center, Klinikum Grosshadern, Ludwig-Maximilians Universität München, Marchioninistrasse 15, D-81377 Munich, Germany.
  • Boeck S; Institute of Pathology, Ludwig-Maximilians Universität München, Thalkirchner Strasse 36, D-80337 Munich, Germany.
Br J Cancer ; 115(12): 1520-1529, 2016 Dec 06.
Article en En | MEDLINE | ID: mdl-27802454
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Osteonectina / Paclitaxel Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2016 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Osteonectina / Paclitaxel Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2016 Tipo del documento: Article País de afiliación: Alemania